ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GARY GOFF M.D.

Internal Medicine

12,644

$908K

377
299 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

36%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

JOHN HUDGINS M.D.

Internal Medicine

11,569

$593K

334
274 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

ASUNCION ACOSTA M.D.

Internal Medicine

10,009

$548K

365
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

NIMISHA MEHTA M.D.

Internal Medicine

7,232

$400K

322
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

LUKE HINSHAW MD

Internal Medicine

20,208

$1.19M

741
540 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

MANSOORA SHEIKH MD

Internal Medicine

12,168

$834K

378
213 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

JANETTE NGUYEN MD

Internal Medicine

10,828

$628K

372
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

MICHELLE MENDOZA M.D.

Internal Medicine

15,049

$192K

454
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$13
Average prescription price

Avg: $67

INES VAZQUEZ MD

Internal Medicine

3,103

$176K

152
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

QUANG LE DO

Internal Medicine

22,387

$1.22M

678
511 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

LAXMAN KALVAKUNTLA M.D.

Internal Medicine

5,314

$404K

277
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $67

STEPHEN MCMAHON MD

Internal Medicine

3,199

$186K

212
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

NICOLE JAMISON MD

Internal Medicine

2,907

$165K

160
144 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

SANJEEV BHATIA M.D.

Internal Medicine

22,214

$1.41M

769
509 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$63
Average prescription price

Avg: $67

JEAN LESLY BRIGHT MD

Internal Medicine

2,765

$130K

178
157 are 65+

24%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

LUIS SABATINI MD

Internal Medicine

8,493

$556K

335
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

KELLEY NEWCOMER MD

Internal Medicine

2,856

$163K

115
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

SYED JAMAL MD

Internal Medicine

12,788

$563K

374
279 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$44
Average prescription price

Avg: $67

ERIC MARKS MD

Internal Medicine

13,036

$852K

402
210 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

41%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $67

DANNEY DREWRY D.O

Internal Medicine

16,066

$1.03M

669
568 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $67

JEREMIAS ABUEME M.D.

Internal Medicine

12,155

$900K

415
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$74
Average prescription price

Avg: $67

DEEPAK PATEL MD

Internal Medicine

25,552

$1.32M

708
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$52
Average prescription price

Avg: $67

DARYL DANIEL MD

Internal Medicine

7,229

$420K

275
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

JEROME LEE SANG MD

Internal Medicine

32,089

$1.87M

1039
880 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

IMRAN NATHANI MD

Internal Medicine

14,354

$966K

548
439 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank